Regulatory

Breakthrough in Genetic Disorder Treatment: GC Pharma’s Sanfilippo Syndrome Drug Receives FDA Phase 1 Approval

by
Sanfilippo,GC Pharma,Regulatory,Treatment,Regulatory

[su_heading size=”27″ align=”left” margin=”40″]Introduction to Sanfilippo Syndrome and GC Pharma’s Efforts[/su_heading] Sanfilippo Syndrome, also known as Mucopolysaccharidosis Type III, is a rare genetic disorder caused by the body’s inability to produce an enzyme necessary for breaking down heparan sulfate. This accumulation leads to severe organ damage and developmental delays. GC Pharma, in collaboration with biotech … Read more

South Korea Advances Regulation on Illegal Content Distribution by CDN Providers

by

[su_heading size=”27″ align=”left” margin=”40″]Introduction to New Regulatory Measures[/su_heading] The South Korean Broadcasting and Telecommunications Commission (KCC) is pushing forward with amendments to the enforcement decree under the Act on Promotion of Information and Communications Network Utilization and Information Protection, etc. This legislative movement comes as a strategic follow-up to the legal provisions established in January, … Read more